Cognetivity Neurosciences Ltd. Stock
Stocks
CGNSF
CA19243C1005
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
OTC Markets
12:19:29 2026-06-25 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | - |
| Market Cap | 1.2M 867K 744K 695K 637K 82.9M 1.22M 8.2M 3.21M 41.58M 3.26M 3.19M 137M | P/E 2022 |
-2.9x | P/E 2023 | -2.8x |
|---|---|---|---|---|---|
| Enterprise Value | 245K 177K 152K 142K 130K 16.96M 249K 1.68M 657K 8.5M 666K 652K 28.12M | EV / Sales 2022 |
-
| EV / Sales 2023 | 437,922,999x |
| Free-Float |
85.56% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -99.00% |
| Current year | 0 |  | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0.14 |
| 5 years | 0 | | 0.7 |
| 10 years | 0 | | 1.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sina Habibi
CEO | Chief Executive Officer | 45 | 2013-03-31 |
Mark Phillips
CMP | Compliance Officer | 67 | 2017-12-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Sina Habibi
BRD | Director/Board Member | 45 | 2016-12-31 |
Mark Phillips
BRD | Director/Board Member | 67 | 2017-12-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/15/24 | Option | Founder | 600,000 | 0.6697% | ||
| 4/15/24 | Option | Founder | 600,000 | 0.6697% | ||
| 6/23/23 | Sell | Founder | 1,108,160 | 1.3030% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -99.00% | -.--% | - | - | 93 | |
| +3.40% | +3.93% | -11.73% | +34.25% | 39.43B | |
| +1.00% | +10.47% | -36.89% | +182.06% | 14.58B | |
| +1.27% | +5.68% | -18.58% | +74.12% | 5.72B | |
| +0.66% | +52.53% | +48.45% | - | 3.93B | |
| +5.53% | +12.46% | - | - | 2.06B | |
| +1.28% | -1.89% | +14.16% | -37.69% | 1.64B | |
| +12.47% | +9.28% | -36.33% | - | 976M | |
| +2.89% | +8.50% | +42.69% | +141.75% | 958M | |
| -4.25% | -8.15% | -38.66% | -48.00% | 811M | |
| Average | -7.78% | +8.92% | -4.61% | +57.75% | 7.01B | |
| Weighted average by Cap. | +0.94% | +7.63% | -13.50% | +70.70% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | - | 0.05 0.03 0.03 0.03 0.02 3.14 0.05 0.31 0.12 1.57 0.12 0.12 5.2 |
| Net income | -13.13M -9.5M -8.15M -7.61M -6.98M -908M -13.34M -89.78M -35.16M -455M -35.67M -34.89M -1.51B | -7.43M -5.38M -4.61M -4.31M -3.95M -514M -7.56M -50.84M -19.91M -258M -20.2M -19.76M -853M |
| Net Debt | -82.43K -59.65K -51.17K -47.78K -43.83K -5.7M -83.79K -564K -221K -2.86M -224K -219K -9.45M | -953K -690K -592K -553K -507K -65.94M -969K -6.52M -2.55M -33.07M -2.59M -2.53M -109M |
Employees
-
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CGNSF Stock
Select your edition
All financial news and data tailored to specific country editions
